作者: AO Dosunmu , EI Uche , Y Kila , AA Akinbami
DOI:
关键词:
摘要: Refractory follicular lymphoma is an indolent malignancy of follicular center cells where a subgroup of disease presents with relapse and refractoriness to treatment or transformation to aggressive diffuse large B cell lymphoma. Improved knowledge of the disease biology is expected to provide means of identifying refractory disease at diagnosis and new approach to their treatment. This systematic review of emerging treatment modalities was done with a view to identifying appropriate treatment of refractory or relapsed follicular lymphoma in resource poor settings. A systematic search of the database of MEDLINE, COCHRANE and EMBASE was done using the following words: relapse/refractory follicular lymphoma, follicular lymphoma clinical trials, follicular lymphoma treatment guideline. Randomized controlled phase II/III trials were selected for review. National Comprehensive Cancer Network and …